INVESTOR RELATIONS
HeadSafe™ created the world's first FDA-cleared portable brain scanner. We're building the global standard for objective brain health assessment.
THE OPPORTUNITY
Concussion is a silent epidemic. According to the World Health Organization, 60 million concussions occur annually — and 50% go undetected or undiagnosed. Current diagnosis relies on subjective testing that can be influenced, minimized, or misreported. HeadSafe™ changes the paradigm with the world's first FDA-cleared portable brain scanner that delivers purely objective brain data in just 2 minutes.
FDA Cleared
The world's first FDA-cleared portable brain scanner for concussion assessment.
Silent Epidemic
60 million concussions annually worldwide, with 50% undetected. Massive unmet need.
Global IP Portfolio
7 international patents protecting our proprietary AI and signal processing technology.
8 Years R&D
Deep science foundation with multi-site validation across Australia, New Zealand, and the U.S.
COMPANY OVERVIEW
HeadSafe™ is a brain health technology company with a mission: every athlete and every patient deserves access to objective brain data. Protecting brains means protecting futures.
Our flagship product, Nurochek™, is the world's first FDA-cleared portable brain scanner. Using proprietary algorithms developed over 8 years, Nurochek™ analyzes over 400,000 data points via Visual Evoked Potentials (VEP) to deliver objective brain assessment in just 2 minutes — no baseline required.
We are actively commercializing across emergency departments, sports medicine programs, neurology practices, urgent care centers, and imaging facilities. Our platform is designed for the field and the clinic — anywhere care is delivered.
Key Milestones
- 1FDA clearance achieved — first portable brain scanner
- 27 international patents protecting core technology
- 38 years proprietary AI research and development
- 4Multi-site validation (Australia, New Zealand, U.S.)
- 5U.S. commercialization actively underway
INVESTOR RESOURCES
INTERESTED IN LEARNING MORE?
Join us in building the global standard for objective brain health assessment. Contact our investor relations team.